187 related articles for article (PubMed ID: 18948021)
1. Percutaneous peritoneovenous shunt for treatment of refractory ascites.
Won JY; Choi SY; Ko HK; Kim SH; Lee KH; Lee JT; Lee DY
J Vasc Interv Radiol; 2008 Dec; 19(12):1717-22. PubMed ID: 18948021
[TBL] [Abstract][Full Text] [Related]
2. Chronological Course and Clinical Features after Denver Peritoneovenous Shunt Placement in Decompensated Liver Cirrhosis.
Koyama S; Nogami A; Yoneda M; Cheng S; Koike Y; Takeuchi Y; Iwaki M; Kobayashi T; Saito S; Utsunomiya D; Nakajima A
Tomography; 2024 Mar; 10(4):471-479. PubMed ID: 38668394
[TBL] [Abstract][Full Text] [Related]
3. Percutaneous peritoneovenous shunt creation for the treatment of benign and malignant refractory ascites.
Park JS; Won JY; Park SI; Park SJ; Lee DY
J Vasc Interv Radiol; 2001 Dec; 12(12):1445-8. PubMed ID: 11742023
[TBL] [Abstract][Full Text] [Related]
4. Radiological insertion of Denver peritoneovenous shunts for malignant refractory ascites: a retrospective multicenter study (JIVROSG-0809).
Sugawara S; Sone M; Arai Y; Sakamoto N; Aramaki T; Sato Y; Inaba Y; Takeuchi Y; Ueno T; Matsueda K; Moriguchi M; Tsushima T
Cardiovasc Intervent Radiol; 2011 Oct; 34(5):980-8. PubMed ID: 21191592
[TBL] [Abstract][Full Text] [Related]
5. Percutaneous implant of Denver peritoneo-venous shunt for treatment of refractory ascites: a single center retrospective study.
Piccirillo M; Rinaldi L; Leongito M; Amore A; Crispo A; Granata V; Aprea P; Izzo F
Eur Rev Med Pharmacol Sci; 2017 Aug; 21(16):3668-3673. PubMed ID: 28925475
[TBL] [Abstract][Full Text] [Related]
6. Peritoneovenous shunting for intractable ascites.
Tyden G; Samnegård H; Thulin L
Acta Chir Scand; 1982; 148(7):597-600. PubMed ID: 7168289
[TBL] [Abstract][Full Text] [Related]
7. Poor outcome from peritoneovenous shunts for refractory ascites.
Scholz DG; Nagorney DM; Lindor KD
Am J Gastroenterol; 1989 May; 84(5):540-3. PubMed ID: 2719011
[TBL] [Abstract][Full Text] [Related]
8. Paracentesis with intravenous infusion of albumin as compared with peritoneovenous shunting in cirrhosis with refractory ascites.
Ginès P; Arroyo V; Vargas V; Planas R; Casafont F; Panés J; Hoyos M; Viladomiu L; Rimola A; Morillas R
N Engl J Med; 1991 Sep; 325(12):829-35. PubMed ID: 1875966
[TBL] [Abstract][Full Text] [Related]
9. Morbidity and mortality after peritoneovenous shunt surgery for refractory ascites.
Rubinstein D; McInnes I; Dudley F
Gut; 1985 Oct; 26(10):1070-3. PubMed ID: 4054706
[TBL] [Abstract][Full Text] [Related]
10. Prognosis assessment of patients with refractory ascites treated with a peritoneovenous shunt.
Nitta H; Okamura S; Mizumoto T; Matsushita H; Nishimura T; Shimokawa Y; Kimura M; Baba H
Hepatogastroenterology; 2013 Oct; 60(127):1607-10. PubMed ID: 24634930
[TBL] [Abstract][Full Text] [Related]
11. Phase I/II study of transjugular transhepatic peritoneovenous venous shunt, a new procedure to manage refractory ascites in cancer patients: Japan Interventional Radiology in Oncology Study Group 0201.
Arai Y; Inaba Y; Sone M; Saitoh H; Takeuchi Y; Shioyama Y; Nakajima Y
AJR Am J Roentgenol; 2011 May; 196(5):W621-6. PubMed ID: 21512054
[TBL] [Abstract][Full Text] [Related]
12. Feasibility of externalized peritoneovenous shunt (EPVS) for malignant ascites.
Tokue H; Takeuchi Y; Arai Y; Sofue K; Sakamoto N; Tsushima Y; Endo K
World J Surg Oncol; 2011 Jul; 9():82. PubMed ID: 21777451
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic results of Denver percutaneous peritoneovenous shunt in cancer patients with malignant ascites.
Tamagawa H; Aoyama T; Inoue H; Fujikawa H; Sawazaki S; Numata M; Sato T; Oshima T; Yukawa N; Morimoto M; Ueno M; Rino Y; Masuda M
J Cancer Res Ther; 2020 Dec; 16(Supplement):S95-S98. PubMed ID: 33380660
[TBL] [Abstract][Full Text] [Related]
14. Implantation of a Denver shunt by left subclavian approach for preventing kinking.
Oida T; Mimatsu K; Kawasaki A; Kanou H; Kuboi Y; Matsuoka S; Amano S
Hepatogastroenterology; 2009; 56(93):1074-7. PubMed ID: 19760944
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic Application of Percutaneous Peritoneovenous (Denver) Shunt in Treating Chylous Ascites in Cancer Patients.
Yarmohammadi H; Brody LA; Erinjeri JP; Covey AM; Boas FE; Ziv E; Maybody M; Gonzalez-Aguirre AJ; Brown KT; Sheinfeld J; Getrajdman GI
J Vasc Interv Radiol; 2016 May; 27(5):665-73. PubMed ID: 26965362
[TBL] [Abstract][Full Text] [Related]
16. Peritoneovenous shunt for refractory ascites: operative complications and long-term results.
Bernhoft RA; Pellegrini CA; Way LW
Arch Surg; 1982 May; 117(5):631-5. PubMed ID: 7073482
[TBL] [Abstract][Full Text] [Related]
17. [Palliative treatment of carcinomatous ascites with peritoneovenous shunt].
Castellví Suaña JM; Baliellas Comellas C; Fabregat Prous J; Torras Torra J; Guardiola Capón J; Sánchez Gili M
Rev Esp Enferm Dig; 1992 Nov; 82(5):331-3. PubMed ID: 1485985
[TBL] [Abstract][Full Text] [Related]
18. Predictive Factors for Treatment Failure after Peritoneovenous Shunt for Hepatic Ascites.
Iida H; Aihara T; Ikuta S; Yamanaka N
Am Surg; 2017 Nov; 83(11):1289-1293. PubMed ID: 29183533
[TBL] [Abstract][Full Text] [Related]
19. The LeVeen shunt in the elective treatment of intractable ascites in cirrhosis. A prospective study on 140 patients.
Smadja C; Franco D
Ann Surg; 1985 Apr; 201(4):488-93. PubMed ID: 3977450
[TBL] [Abstract][Full Text] [Related]
20. Short- and long-term effectiveness, morbidity, and mortality of peritoneovenous shunt inserted to treat massive refractory ascites of nephrogenic origin analysis of 14 cases.
Holm A; Rutsky EA; Aldrete JS
Am Surg; 1989 Nov; 55(11):645-52. PubMed ID: 2479308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
